| Name | Hy-vee Pharmacy 1068 |
|---|---|
| Organization Name | Hy Vee Inc |
| Location | 800 N 2nd St, Cherokee, Iowa 51012 |
| Type | Community/Retail Pharmacy |
| Phone | (712) 225-6121 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
According to a warning from the United States Food and Drugs Administration (FDA), devices that are being sold for "vaginal rejuvenation" in women who are suffering from urinary incontinence or menopausal and sexual symptoms, can cause serious harm.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
› Verified 9 days ago
| NPI Number | 1871538298 |
| Organization Name | VALLEY PHARMACY CORP |
| Type | Community/Retail Pharmacy |
| Address | 800 N 2nd St, Cherokee, IA 51012 |
| Phone Number | 712-225-6121 |
News Archive
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
According to a warning from the United States Food and Drugs Administration (FDA), devices that are being sold for "vaginal rejuvenation" in women who are suffering from urinary incontinence or menopausal and sexual symptoms, can cause serious harm.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
› Verified 9 days ago
| NPI Number | 1881811784 |
| Organization Name | HY-VEE INC |
| Doing Business As | HY VEE PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 800 N 2nd St, Cherokee, IA 51012 |
| Phone Number | 712-225-6121 |
News Archive
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
According to a warning from the United States Food and Drugs Administration (FDA), devices that are being sold for "vaginal rejuvenation" in women who are suffering from urinary incontinence or menopausal and sexual symptoms, can cause serious harm.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
› Verified 9 days ago
News Archive
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
According to a warning from the United States Food and Drugs Administration (FDA), devices that are being sold for "vaginal rejuvenation" in women who are suffering from urinary incontinence or menopausal and sexual symptoms, can cause serious harm.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
› Verified 9 days ago
Cherokee Main Street Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 218 E Main St, Cherokee, Iowa 51012 Phone: (712) 225-2320 | |
Hy-vee Pharmacy 1068 Type: Community/Retail Pharmacy Location: 800 N 2nd St, Cherokee, Iowa 51012 Phone: (712) 225-6121 | |
Family Vision Clinic Type: Medicare Supplier Location: 208 W Bluff St, Cherokee, Iowa 51012 Phone: (712) 225-6151 | |
Wendell Stoelting O.d., P.c. Type: Medicare Supplier Location: 215 West Willow Street, Cherokee, Iowa 51012 Phone: (712) 225-3822 |